Non Hodgkin Lymphoma:
|
|
- Marcus Chandler
- 8 years ago
- Views:
Transcription
1 Non Hodgkin Lymphoma: Non Hodgkin Lymphoma, often referred to as NHL, is a cancer originating in the lymphocytes, a type of blood cell, which are integral to the body s immune system. Non Hodgkin Lymphoma accounts for approximately 4% of all cancers in the United States. SEER data (Surveillance, Epidemiology and End Results) program of the National Institutes of Health estimates cases to be diagnosed in 2015 at 71,850 (39, 850 males and 32,00 females). Deaths in 2015 are expected be around 19,790, including 11,480 men and 8,310 women. Ninety five percent of Non Hodgkin Lymphoma is diagnosed in adults. This report is limited to adult cases only. The most common age range for the development of NHL is 65 74, with the average age being 66. Our immune system is very complex and consists of immune protecting cells, organs and lymph system. There are two types of lymphocytes that are key to the immune system, B lymphocytes and T lymphocytes. The B lymphocytes, or B cells are involved in the making of antibodies, which attach themselves to foreign substances, like germs or viruses, and they facilitate the destruction of these cells in the body. The T lymphocytes, or T cells are also involved in the immune system. Various types of T cells protect the body by directly or indirectly destroying various bacteria, fungi or viruses. The B cells and T cells are part of the Lymphatic system, often called the lymph system, which also includes lymph vessels, lymphoid tissues and related organs like the spleen and bone marrow. The lymph vessels run through the body, almost parallel to the blood vessels. They carry lymph fluid, lymphocytes and help clear the body of infection, and debris. Lymph nodes are organs located throughout the body and are connected by the lymph vessels. Lymph nodes can be felt in the neck, armpit or axilla and groin, but are located in other parts of the body. Lymph nodes enlarge when the body is fighting infection and are found normally when someone has a cold or other infection. However, enlarged lymph nodes are the most common sign of Lymphoma and are part of any diagnosis of NHL.
2 The spleen, thymus, adenoids, tonsils, bone marrow and parts of the stomach and intestines are organs that are part of this system and make lymphocytes, antibodies or lymphoid tissue. Non Hodgkin Lymphoma: Subtypes There are many different types of Non Hodgkin Lymphoma. This is an extensive list, but there are rare types not necessarily included in this summary. NHL B Cell Lymphomas B Cell Lymphomas comprise nearly 85% of all presentations of Non Hodgkin Lymphoma in the U.S. The table below summarizes their occurrence and characteristics. Table 1. B Cell Lymphoma Type Occurrence Characteristics Diffuse Large B cell The most common type Fast growing, responds Lymphoma (DLBCL) of NHL, approximately 1/3 of cases present with this diagnosis well to treatment. 75% of patients have a complete response after initial treatment. Primary Mediastinal B Approximately 2% of all Subtype of DLBCL. cell Lymphoma (a DLBCL sub type) frequently in young patients, under 40. About 2/3 of the patients are women Intravasular Large B cell Lymphoma (a DLBCL sub type) lymphomas. Occurs more Involves fibrosis tissue in the cells. Fast growing, responds well to treatment. Rare Subtype of DLBCL Lymphoma cells are found inside the blood vessels only and not in other organs common to lymphoma
3 B Cell Lymphoma Type Occurrence Characteristics Follicular Lymphoma Approximately 20% of all lymphomas Rare in young people, average age at diagnosis is about 60 years. Cells grow in a circular pattern. Slow growing May convert to a fast growing DLBCL Small Lymphocytic Approximately 5 10% of Slow growing Lymphoma (SLL), and all lymphomas are SLL Cancer cells are mainly in the lymph nodes and spleen Mantle Cell Lymphoma Marginal zone B cell lymphomas Extranodal marginal zone B cell lymphoma, also known as mucosaassociated lymphoid tissue (MALT) (a subtype of Marginal zone B cell lymphoma) Approximately 5% of all lymphomas More common in men Average age at diagnosis is about 60 years. Approximately 5 10% of all lymphomas Most common of the marginal zone B cell lymphomas Average age at diagnosis is about 60 years. Usually slow growing. 3 main sub types Initiate outside the lymph nodes Linked to Helicobacter pylori, the bacteria causing stomach ulcers May originate in other organs Usually confined and does not metastasize Nodal Marginal zone B Rare Ususally stays in the Cell lymphoma Found most often in older lymph nodes (a subtype of Marginal women Slow growing zone B cell lymphoma) Splenic marginal zone B cell lymphoma (a subtype of Marginal zone B cell lymphoma) Rare Most often elderly and male Slow growing Usually in spleen and bone marrow only.
4 B Cell Lymphoma Type Occurrence Characteristics Burkitt Lymphoma 1 2% of all Lymphomas Endemic type is rare in the US 90% of patients are male Usually diagnosed around age of 30 Burkitt like lymphoma type usually starts in the abdomen, or reproductive organs Slow growing Lymphoplasmacytic Lymphoma 1 2% of all lymphomas Found primarily in spleen, lymph nodes and bone marrow Hairy Cell Leukemia (HCL) Rare Cells have a hairy Despite the name, often Men more likely to be appearance considered a Lymphoma diagnosed than women Average age at diagnosis is 50 Usually found in the spleen, bone marrow and blood Slow growing Primary Central nervous Rare Poor outlook system (CNS) Lymphoma More common in people with immune system disorders Found in the brain, spinal cord, tissues around the spinal cord and eye.
5 T Cell Lymphomas T Cell Lymphoma Type Occurrence Characteristics Precursor T lymphoblastic lymphoma Peripheral T cell lymphomas Cutaneous T cell lymphomas (mycosis fungoides, Sezary syndrome and others Adult T cell Lymphoma Smoldering (Adult T cell Lymphoma subtype) Chronic (Adult T cell Lymphoma subtype) Comprises about 1% of all lymphomas Most often young adults Males develop more frequently than females Rare About 5% of all lymphomas Rare in the US More common in Japan, Africa and the Caribbean Rare in the US More common in Japan, Africa and the Caribbean Rare in the US More common in Japan, Africa and the Caribbean May present as leukemia or lymphoma Often starts in the thymus gland, where T cell are made May present in the center of the chest (mediastinum) and impact breathing or blood return to the heart Develop from mature T cells Start in the skin Begins with infection by a virus called HTLV 1. Grows slowly Abnormal T cells without increased lymphocytes My involve the skin or lungs Grows slowly Increased total lymphocytes and T cells May involve skin, lungs, liver, spleen and lymph nodes
6 T Cell Lymphoma Type Occurrence Characteristics Acute (Adult T cell Lymphoma subtype) Rare in the US More common in Japan, Africa and the Caribbean Acts like acute leukemia Fast growing High lymphocyte and T cell counts Enlarged lymph nodes, liver and spleen Fever, night sweats and Lymphoma (Adult T cell Lymphoma subtype) Angioimmunoblastic T cell lymphoma Extranodal natural killer/t cell lymphoma, nasal type Enteropathy associated intestinal T cell lymphoma (EATL) Type I EATL Type II EATL Rare in the US More common in Japan, Africa and the Caribbean 3% of all lymphomas More common in older adults Rare More common in parts of Asia and South America Rare Rare More common in men than women Tends to occur in people in their 60 s and 70 s. Less common than EATL Type I weight loss occur Enlarged lymph nodes without increased lymphocytes or T cells Enlarged lymph nodes, liver and spleen Fever, night sweats and weight loss occur Involves upper airway passages, but can also affect the skin and digestive tract. Occurs in various places within the lining of the intestine. May experience nausea, vomiting and abdominal pain Aligned with glutensensitivity enteropathy (celiac disease or sprue). Is not linked to sprue
7 T Cell Lymphoma Type Occurrence Characteristics Anaplastic large cell lymphoma (ALCL) Peripheral T cell lymphoma unspecified About 2% of all lymphomas More common in young people, but does occur at ages 50+ About half of all T cell lymphomas Average age of acquiring is in the 60 s. Starts in the lymph nodes Spreads to the skin Fast growing Do not fit into other groups Fast growing
8 Total Cases of Non Hodgkin Lymphoma The Sac Sierra Region Treated 155 cases of Non Hodgkin Lymphoma in These cases were distributed over our four ACoS sites, with 13 at SAFH, 87 at SMCS, 43 at SRMC and 12 at SSMC. Graph SAFH SMCS SRMC SSMC 2014 NHL Volumes
9 Risk Factors: Age, Gender, Race Presence Among the Sutter Health Sac Sierra Region Population Age: Like many cancers, age is correlated with the development of NHL. Average age for diagnosis is 65 74, with the average age being 66. Below is a graph demonstrating the distribution of Non Hodgkin Lymphoma patients seen within the SHSSR in 2014 by age at diagnosis. Graph Age Distribution of Patients with NHL < =>90 SAFH SMCS SRMC SSMC SHSSR
10 Gender: Non Hodgkin Lymphoma is more common among men that females, yet some types of NHL are more prevalent with females. Below is the distribution of patient seen in the SHSSR, 2014, by gender. Graph 3 SHSSR Gender Distribution at Time of Diagnosis 52% 48% Female Male Graph 4 SAFH Gender Distribution at Time of Diagnosis SMCS Gender Distribution at Time of Diagnosis 62% 38% Female Male 52% 48% Female Male SRMC Gender Distribution at Time of Diagnosis SSMC Gender Distribution at Time of Diagnosis 47% 53% Female Male 58% 42% Female Male
11 Race: Non Hodgkin Lymphoma is seen more often in Caucasians than African Americans and Asian Americans in the United States. There are some NHL s that are associated with specific countries or cultures (demonstrated in the Table 1.) Below is the distribution by Race of patients seen at SHSSR with a diagnosis of NHL in 2014 (Graph 5). 1% 1% 2% SHSSR % 2%1% 88% White Black Filipino Asian Indian or Pakistaninos Japanese Pacific Islander NOS Unknown SAFH % White 1% 1% 2% 4% 7% 85% SMCS 2014 White Black Filipino Asian Indian or Pakistaninos Japanese Pacific Islander NOS Unknown SRMC 2014 SSMC % 2% White 96% Black Filipino Asian Indian or Pakistaninos Japanese 16% 17% 67% White Black Filipino
12 STAGING Cancers are diagnosed by many modalities, including but not limited to biopsy, physical symptoms, lab tests, x rays, CT s (computerized tomography), bone marrow evaluation, MRI (Magnetic Resonance Imaging) and other interventional diagnostic tests. When the physician has received all the relevant data, one is categorized as a particular stage of disease. For Non Hodgkin Lymphoma, there are four stages of disease, I, II, III, and IV. In general, the higher the number, the more advanced the disease. Additionally, each number is assigned either an A or B designation. Patients receiving a B designation have the presence of, 1) Unexplained fevers greater than degrees, 2) Drenching night sweats and 3) Unexplained weight loss of more than 10% of usual body weight. Patients receiving an A designation have the absence of B symptoms. Per the American Joint Committee on Cancer, the Anatomic Staging for Non Hodgkin Lymphoma is listed below. Table 2 Stage I Stage II Stage III Stage IV Involvement of a single lympahatic site (i.e., nodal region, Waldeyer s ring, thymus or spleen) (I) or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with r without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by an Arabic numeral, as in for example II3. Involvement of lymph node regions on both sides of the diaphragm (III), which also maybe accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). Splenic involvement is designated by the letter S. Diffuse or disseminated involvement of one or more
13 extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement but in conjunction with disease in distant site(s). Stage IV includes any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid.
14 Below is the distribution of 2014 Non Hodgkin Patients by Stage at each site of the SHSSR. (Graph 6) A 1B 2A 2B 3A 3B 4A 4B 0 Unstaged SHSSR SAFH A 1B 2A 2B 3A 3B 4A SMCS A 1B 2A 2B 3A 3B 4A A 1B 2A A 1B 2A B 3A 3B B 3A 3B SRMC A SSMC A
15 A comparison of SHSSR staging data to SEER staging data from demonstrates very similar distribution of stage between these data. 50% Percent of Cases by Stage SEER Data % 28% 15% Localized Regional Distant Unknown 59% Percent of Cases by Stage SHSSR % 20% 16% Localized Regional Distant Unknown 56% Percent of Cases by Stage SAFH % 22% 12% Localized Regional Distant Unknown 63% Percent of Cases by Stage SMCS % 17% 16% Localized Regional Distant Unknown 52% Percent of Cases by Stage SRMC % 25% 16% Localized Regional Distant Unknown 58% Percent of Cases by Stage SSMC % 20% 20% Localized Regional Distant Unknown
16 Survivorship Statistics for Non Hodgkin Lymphoma. The SEER data (Surveillance, Epidemiology and End Results) program of the National Institutes of Health, provides a national statistical data base to evaluate survivorship percentages of patients diagnosed with Non Hodgkin Lymphoma. The most recent data available is from % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 5 Year Relative Survival Rate SEER Data Localized Regional Distant Unstaged Compare this with the SHSSR Survival Data 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 5 Year Relative Survival Rate SHSSR Localized Regional Distant Unstaged
17 Below is the data by Facility, including SAFH, SMCS, SRMC, and SSMC 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 5 Year Relative Survival Rate SAFH Localized Regional Distant Unstaged 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 5 Year Relative Survival Rate SMCS Localized Regional Distant Unstaged 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 5 Year Relative Survival Rate SRMC Localized Regional Distant Unstaged 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 5 Year Relative Survival Rate SSMC Localized Regional Distant Unstaged TREATMENT Non Hodgkin Lymphoma is a disease primarily treated by chemotherapy and monoclonal antibodies. Surgery and Radiation play a role in some NHL types in early stage disease. Some patients may benefit from bone marrow transplant as a treatment modality. The Sutter Health Sac Sierra Region and four ACoS hospitals, Sutter Auburn Faith Hospital, Sutter Medical Center, Sacramento, Sutter Roseville Medical Center and Sutter Solano Medical Center are fortunate to be able to utilize the Bone and Marrow Transplant Program housed at Sutter Medical Center, Sacramento as part of the treatment resources for our patients.
18 The Bone and Marrow Transplant Center The Bone and Marrow Transplant Center for the Sutter Health Sac Sierra Region is housed at Sutter Medical Center, Sacramento. It opened in Currently, this unit has 16 beds. Our Blood and Marrow Transplant (BMT) Program supports fulfillment of a substantial community need and enhances community access with a full service program providing autologous, related, Haploidentical, matched unrelated allogeneic and cord blood transplants. An extensive number of diseases of the bone marrow may also result in consideration of BMT as a treatment modality. Those include, but are not limited to bone marrow failure, chronic leukemia, Hodgkin s disease, immune hematologic disorders, immunotherapy, Acute Leukemia, Multiple Myeloma, Myeloproliferative diseases and Non Hodgkin s Lymphoma. The BMT Program partners with National Marrow Donor Program (NMDP) to search for volunteer unrelated donors. The goal of the BMT Program is to achieve the highest standards of quality in all business units practice and operations without compromising patient safety. The BMT Program is accredited by the Foundation of Cellular Therapy (FACT) allogeneic and autologous transplants, Hematopoietic Stem Cell Collection of Peripheral Cells and Bone Marrow Harvest for patients diagnosed with leukemia, lymphoma, multiple myeloma and other blood disorders. Our team is led by Dr. Michael Carroll, M.D., Medical Director and Dr. Elias Kiwan, M.D. In addition, a large team of patient care coordinators, social workers, financial coordinators, nurses, quality assurance specialist, and patient advocates, who are familiar with the issues and care of transplant patients work together to provide a coordinated service to meet the needs of this unique patient population.
19 Dr. Michael Carroll, M.D., is the Medical Director of the Blood and Marrow Transplant Service for the Sutter Cancer Centers Valley Operating Unit. Dr. Carroll has been with Sutter Medical Group since 2008, building the program into a state of the art treatment center for patients. Dr. Carroll graduated from Stanford University School of Medicine, Completed his Internship and Residency at the University of Chicago and his Fellowship in Hematology/Oncology at the Johns Hopkins University School of Medicine. Dr. Carroll is a member of the American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation. Dr. Elias Nicolas Kiwan, MD, joined Sutter Medical Group in 2011 and expanded the Medical Oncology Team providing care to the patients within the Sutter Health Network requiring Blood and Marrow Transplant Services. Dr. Kiwan graduated from The Lebanese University Faculty of Medicine in Beirut Lebanon. He Completed his Internship and Residency at the University of Arkansas for Medical Sciences. Dr. Kiwan then completed his
20 Medical Oncology Hematology Fellowship and Research at the University of Arkansas for Medical Sciences, Bone marrow Transplant Unit. He is a member of the American Medical Association, American Society of Hematology and American Society of Clinical Oncology. He is fluent in English, French and Arabic. Information regarding management of patients with Non Hodgkin Lymphoma or the Bone and Marrow Transplant Center may be found at References will be added.
Aggressive lymphomas. Michael Crump Princess Margaret Hospital
Aggressive lymphomas Michael Crump Princess Margaret Hospital What are the aggressive lymphomas? Diffuse large B cell Mediastinal large B cell Anaplastic large cell Burkitt lymphoma (transformed lymphoma:
More informationLymphoma Diagnosis and Classification
Lymphoma Diagnosis and Classification By Atef Shrit, MD, Pathology B- and T/NK-cell lymphomas are clonal neoplasms of immature and mature B-lymphocytes, T-lymphocytes or natural killer cells at various
More informationMALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)
MALIGNANT LYMPHOMAS Dr. Olga Vujovic (Updated August 2010) Malignant lymphomas consist of Hodgkin and non-hodgkin lymphomas. The current management of these diseases involves a multi-disciplinary approach.
More informationNon-Hodgkin Lymphoma
Non-Hodgkin Lymphoma What is non-hodgkin lymphoma? Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas
More informationEstimated New Cases of Leukemia, Lymphoma, Myeloma 2014
ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the
More informationNon-Hodgkin s Lymphoma
Non-Hodgkin s Lymphoma Luis Fayad, MD Assistant Professor Clinical Medical Director Lymphoma/Myeloma Department Non-Hodgkin s Lymphoma Non-Hodgkin s lymphomas (NHL) are a heterogeneous group of malignant
More informationCollaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma (CALM) Additional Questionnaire (MED C) INCLUSION CRITERIA CALM STUDY
Additional Questionnaire (MED C) CALM study Inclusion period: 01/01/2008 to 31/12/2011 PATIENT REGISTRATION FORM Disease Diagnosis Lymphoma S Non Hodgkin Lymphoma (NHL) Mature B-cell neoplasm Follicular
More informationTable 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006
Multiple Myeloma Figure 16 Definition: Multiple myeloma forms in plasma cells that are normally found in the bone marrow. 1 The plasma cells grow out of control and form tumors (plasmacytoma) or crowd
More informationAcute Myeloid Leukemia
Acute Myeloid Leukemia Introduction Leukemia is cancer of the white blood cells. The increased number of these cells leads to overcrowding of healthy blood cells. As a result, the healthy cells are not
More informationMany people with non-hodgkin lymphoma have found an educational support group helpful. Support
Track 2: Treatment Options [Narrator] Many people with non-hodgkin lymphoma have found an educational support group helpful. Support groups take many forms: some meet the needs of people with all kinds
More informationNon-Hodgkin Lymphoma Richard Orlowski, MD
Non-Hodgkin Lymphoma Richard Orlowski, MD The American Cancer Society (ACS) estimates that 69,740 Americans will be diagnosed with non-hodgkin lymphoma (NHL) in 2013. Excluding non-melanoma skin cancers,
More informationRADIATION THERAPY FOR LYMPHOMA. Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY
RADIATION THERAPY FOR Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT The lymphatic system is a network of tiny vessels extending
More informationThymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
More informationNon-Hodgkin Lymphoma. Understanding your diagnosis
Non-Hodgkin Lymphoma Understanding your diagnosis Non-Hodgkin Lymphoma Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the
More informationBone Marrow (Stem Cell) Transplant for Sickle Cell Disease
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient
More informationCutaneous Lymphoma FAST FACTS
Cutaneous Lymphoma FAST FACTS What is Cutaneous Lymphoma? Cutaneous lymphomas are types of non-hodgkin s lymphomas (NHL) that originate in the lymphocytes (white blood cells). Unlike most other types of
More informationOncology Best Practice Documentation
Oncology Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Solid Tumors Lymphomas Leukemias Myelodysplastic Syndrome Pathology Findings
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationUnderstanding Non-Hodgkin Lymphoma
Understanding Non-Hodgkin Lymphoma A Guide For Patients, Survivors, and Loved Ones Fourth Edition This guide is an educational resource compiled by the Lymphoma Research Foundation (LRF) that provides
More informationPROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA
2012 1 31,, PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA Version 1.0 2012 DIVISION OF HAEMATOLOGY / ONCOLOGY DEPARTMENT OF MEDICINE KAOHSING VETERAN GENERAL HOSPTIAL General Guide Diagnosis 1.Adequate
More informationLow grade non-hodgkin Lymphoma
Low grade non-hodgkin Lymphoma www.lymphomas.org.uk The knowledge to challenge lymphatic cancers The Lymphoma Association provides: freephone helpline emotional support for those affected by lymphomas
More informationNon-Hodgkin Lymphoma. National Cancer Institute. What You Need TM. To Know About
National Cancer Institute What You Need TM To Know About Non-Hodgkin Lymphoma U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Contents About This Booklet 1 What Is Non-Hodgkin
More informationLYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis
LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the
More informationLeukemias and Lymphomas: A primer
Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes
More informationBlood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
More informationHigh-grade non-hodgkin lymphoma (NHL) Patient information
High-grade non-hodgkin lymphoma (NHL) Patient information My details This is a place to put important information about you, your condition and key contacts. Name and hospital number My NHS number My condition
More informationOvarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health
Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public
More informationLeukaemia and lymphoma what s the difference?
Freephone helpline 0808 808 5555 information@lymphomas.org.uk www.lymphomas.org.uk Leukaemia and lymphoma what s the difference? This is a difficult question to answer simply but it is one that is often
More informationMalignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
More informationLymphoma. Starting Point. Diagnosed with Lymphoma?
ESSENTIALS Lymphoma Diagnosed with Lymphoma? It s important to understand everything you can about your diagnosis, treatment options, and places to go for support. This will help you make treatment decisions
More informationHodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla
Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy
More informationPediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
More informationGeneral Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
More informationCanine Lymphoma Frequently Asked Questions by Pet Owners
Canine Lymphoma Frequently Asked Questions by Pet Owners What is lymphoma? The term lymphoma describes a diverse group of cancers in dogs that are derived from white blood cells called lymphocytes. Lymphocytes
More informationLYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons
LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:
More informationNon-Hodgkin s Lymphoma. Treatment Guidelines for Patients
Non-Hodgkin s Lymphoma Treatment Guidelines for Patients Version II/ December 2004 Non-Hodgkin s Lymphoma Treatment Guidelines for Patients Version II/ December 2004 The goal of the National Comprehensive
More informationSymptoms of Hodgkin lymphoma
Produced 28.02.2011 Revision due 28.02.2013 Symptoms of Hodgkin lymphoma Lymphoma is a cancer of cells called lymphocytes. These cells are part of our immune system, which helps us to fight off infections.
More informationAcute myeloid leukemia (AML)
Acute myeloid leukemia (AML) Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. Adult
More informationNarrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
More informationYour NHL Journey. RITUXAN for Follicular Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL) Indications. Important Safety Information
* Your NHL Journey RITUXAN for Follicular Lymphoma and Diffuse Large B-cell Lymphoma (DLBCL) * Non-Hodgkin s Lymphoma Indications RITUXAN (rituximab) is indicated for the treatment of: Follicular CD20-positive
More informationOncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control
Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with
More informationThe Treatment of Leukemia
The Treatment of Leukemia Guest Expert: Peter, MD Associate Professor of Hematology Director, Yale Cancer Center Leukemia Program www.wnpr.org www.yalecancercenter.org Hi, I am Bruce Barber and welcome
More informationWhat is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
More informationA 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on
A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on examination. She also has fever, weight loss, and sweats. What
More informationMesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1
Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this
More informationHodgkin and Non-Hodgkin Lymphoma Pre-HCT Data
(Form 2018) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data Form. E-mail comments regarding the content
More informationCLL. Handheld record. Stockport NHS foundation trust
CLL 2015 Handheld record Contains- Patient information booklet, details of haematology clinic assessment and ongoing clinical assessment at GP surgery Stockport NHS foundation trust You have been diagnosed
More informationBone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation
More informationAcute myeloid leukaemia (AML) in children
1 61.02 Acute myeloid leukaemia (AML) in children AML can affect children of any age, and girls and boys are equally affected. Leukaemia Acute myeloid leukaemia (AML) FAB classification of AML Causes of
More informationLauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
More informationHow CanCer becomes critical in the claims
How CanCer becomes critical in the claims arena Cancer is a disease in which cells in your body grow in an uncontrolled way and form a lump called a tumour. In a healthy individual cells grow and reproduce
More informationLymph Nodes and Cancer What is the lymph system?
Lymph Nodes and Cancer What is the lymph system? Our bodies have a network of lymph vessels and lymph nodes. (Lymph is pronounced limf.) This network is a part of the body s immune system. It collects
More informationIntroduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
More informationDEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT
www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers
More informationGallbladder Diseases and Problems
Gallbladder Diseases and Problems Introduction Your gallbladder is a pear-shaped organ under your liver. It stores bile, a fluid made by your liver to digest fat. There are many diseases and problems that
More informationLung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD
Public Outcomes Report Lung Cancer Submitted by Omar A. Majid, MD Lung cancer is the most common cancer-related cause of death among men and women. It has been estimated that there will be 226,1 new cases
More informationUnderstanding How Existing and Emerging MS Therapies Work
Understanding How Existing and Emerging MS Therapies Work This is a promising and hopeful time in the field of multiple sclerosis (MS). Many new and different therapies are nearing the final stages of
More informationLIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
More informationCoding for Lymphoma. Audio Seminar/Webinar. Practical Tools for Seminar Learning. February 28, 2008
Audio Seminar/Webinar February 28, 2008 Practical Tools for Seminar Learning Copyright 2008 American Health Information Management Association. All rights reserved. Disclaimer The American Health Information
More informationBrain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
More informationAdult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2
Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2 Leukaemia: Description A group of malignant disorders affecting: White blood cells (lymphocytes or leucocytes) Bone
More informationCancer in Children. What is cancer?
What is cancer? Cancer in Children The body is made up of trillions of living cells. Normal body cells grow, divide to make new cells, and die in an orderly fashion. During the early years of a person
More informationRESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
More informationMultiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
More informationUnderstanding. Pancreatic Cancer
Understanding Pancreatic Cancer Understanding Pancreatic Cancer The Pancreas The pancreas is an organ that is about 6 inches long. It s located deep in your belly between your stomach and backbone. Your
More informationHOVON Staging and Response Criteria for Non-Hodgkin s Lymphomas Page 1
HOVON Staging and Response Criteria for Non-Hodgkin s Lymphomas Page 1 This document describes the minimally required staging and evaluation procedures and response criteria that will be applied in all
More informationMantle Cell Lymphoma and New Treatments on the Horizon
MANTLE CELL LYMPHOMA Mantle Cell Lymphoma and New Treatments on the Horizon Presented by James Armitage, MD University of Nebraska Medical Center Pierluigi Porcu, MD The Ohio State University Comprehensive
More informationEarly Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
More informationSpecific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also
More informationBlood, Lymphatic and Immune Systems
Component 3-Terminology in Healthcare and Public Health Settings Unit 4-Blood, Lymphatic and Immune Systems This material was developed by The University of Alabama at Birmingham, funded by the Department
More informationBlood-Forming Stem Cell Transplants
Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic
More informationBone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer
Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer A Review of the Research for Parents and Caregivers Is This Information Right
More informationQ: Why is there a need for people to join the Be The Match Registry?
Q: Why is there a need for people to join the Be The Match Registry? A: Thousands of patients with blood cancers like leukemia and lymphoma, sickle cell and other life-threatening diseases depend on the
More informationUnderstanding Metastatic Disease
Supported by an unrestricted educational grant from Pfizer Understanding Metastatic Disease Metastatic disease or metastases are phrases that mean the same as Secondary cancer. This means that the cancer
More informationChildhood Non-Hodgkin Lymphoma
Understanding Childhood Non-Hodgkin Lymphoma A Guide for Patients, Survivors and Loved Ones First Edition Understanding Childhood Non-Hodgkin Lymphoma A Guide for Patients, Survivors and Loved Ones First
More informationFollicular lymphoma. What is follicular lymphoma? Freephone helpline 0808 808 5555 information@lymphomas.org.uk www.lymphomas.org.
Freephone helpline 0808 808 5555 information@lymphomas.org.uk www.lymphomas.org.uk is a cancer of the lymphatic system, a type of non-hodgkin lymphoma. Even though more than 12,000 people are diagnosed
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationIntroduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each
Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including
More informationUnderstanding Hodgkin Lymphoma
Understanding Hodgkin Lymphoma A Guide For Patients, Survivors, and Loved Ones Fourth Edition This guide is an educational resource compiled by the Lymphoma Research Foundation (LRF) that provides general
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll
More informationC a nc e r C e nter. Annual Registry Report
C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases
More informationCHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
More informationwww.e-mercy.com Mercy Health Fairfield Hospital Annual Report on 2010 Activities Non-Hodgkin Lymphoma Outcomes Study
www.e-mercy.com Mercy Health Fairfield Hospital Annual Report on 2010 Activities Non-Hodgkin Lymphoma Outcomes Study Cancer Program Summary The Cancer Program at Mercy Health - Fairfield Hospital has maintained
More information95% of childhood kidney cancer cases are Wilms tumours. Childhood kidney cancer is extremely rare, with only 90 cases a year in
James Whale Fund for Kidney Cancer Childhood kidney cancer factsheet Kidney cancer rarely afflicts children and about 90 paediatric cases are diagnosed in the UK each year. About 75% of childhood kidney
More informationThe Lymphoma Guide Information for Patients and Caregivers
The Lymphoma Guide Information for Patients and Caregivers Ashton, lymphoma survivor This publication was supported in part by grants from Revised 2013 A Message From John Walter President and CEO of The
More information2.1 Who first described NMO?
History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first
More informationAbout B Cell Lymphomas Groupmeeting Klipp/Spang, December 09 2002 Dennis Kostka Max-Planck-Institute for Molecular Genetics Computational Molecular Biology Berlin 1 Overview Short History of Lymphoma Classification
More informationThe Immune System. How your immune system works. Organs of the Immune System
UW MEDICINE PATIENT EDUCATION The Immune System How your immune system works The immune system is a network of special cells, tissues, and organs that defend the body against attacks from foreign invaders,
More informationAn overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham
An overview of CLL care and treatment Dr Dean Smith Haematology Consultant City Hospital Nottingham What is CLL? CLL (Chronic Lymphocytic Leukaemia) is a type of cancer in which the bone marrow makes too
More informationBone Marrow/Stem Cell Transplant
Blue Distinction Centers for Transplants Program Selection Criteria for 2010 Mid-Point Designations To qualify as a Blue Distinction Center for Transplants (), each facility must satisfy s quality based
More informationPATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES.
PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES. Radiation Oncology Sidney Kimmel Cancer Center at Johns Hopkins Last
More informationSummary of the risk management plan (RMP) for Accofil (filgrastim)
EMA/475472/2014 Summary of the risk management plan (RMP) for Accofil (filgrastim) This is a summary of the risk management plan (RMP) for Accofil, which details the measures to be taken in order to ensure
More informationThings You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
More informationMesothelioma: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
More informationI was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several
Track 3: Goals of therapy I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several factors she ll use to decide what s best for me. Let s talk about making treatment
More informationBile Duct Diseases and Problems
Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.
More informationLung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.
Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette
More informationUnderstanding Pleural Mesothelioma
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
More informationCancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.
Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific
More informationCord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD
Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer
More information